54 articles by Ricky Zipp
-
J&J returns to growth in Q1 as elective care rebounds in US, Asia-Pacific
April 20, 2021 -
BD Alaris pump recall again labeled Class I event by FDA
April 19, 2021 -
EU MDR delay has not made new rules easier to stomach: exec poll
April 15, 2021 -
iRhythm's future hazy after Medicare pricing saga erases 12-month high
April 13, 2021 -
iRhythm shares tank after Medicare rates surprise
April 12, 2021 -
Medtronic's robotic spine market lead threatened as smaller rivals look to edge in
April 9, 2021 -
Medtechs top pharma in cash to doctors for consulting, travel: Health Affairs study
April 6, 2021 -
Quest sells minority share of Q2 Solutions for $760M
April 1, 2021 -
Stryker, Zimmer make data and analytics a top priority as robotic procedures ramp up
March 25, 2021 -
Insulet's Omnipod 5 trial shows benefits across patient groups with Type 1 diabetes
March 22, 2021 -
ASCs gave medtechs alternate care sites amid pandemic hospital elective shutdown
March 19, 2021 -
CGM patients seen rising 38% in 2021 fueled by Type 2 diabetes: poll
March 18, 2021 -
Robotics demand held firm as pandemic pummeled electives
March 18, 2021 -
Abbott halts trial enrollment for HeartMate PHP catheter blood pump
March 17, 2021 -
All eyes on elective care after a rollercoaster year for medtech
March 16, 2021 -
Cardiac wearables, iRhythm, under a cloud as reimbursement questions linger
March 15, 2021 -
Insulin pump adoption seen climbing 21% in 2021 on wearables boom: survey
March 5, 2021 -
Boston Scientific puts up $1B in cash to buy Lumenis surgical line from private equity
March 3, 2021 -
iRhythm still faces reimbursement uncertainty after meetings with Medicare rate negotiator
Feb. 26, 2021 -
Diabetes wearables look resilient through 2021, bucking broad medtech trends
Feb. 25, 2021 -
BD drug-coated balloon falls short at FDA panel, signaling likely rejection
Feb. 18, 2021 -
Dexcom touts boost from Super Bowl ad, sidesteps access complaints
Feb. 12, 2021 -
What medtech earnings tell us so far: COVID-19 testing, electives hit, and M&A
Feb. 11, 2021 -
Dexcom's Super Bowl ad puts focus on cost, access issues in diabetes tech
Feb. 9, 2021 -
Zimmer takes electives hit in Q4, to spin off spine, dental units
Feb. 5, 2021